1352926-03-4 Usage
Uses
Used in Organic Synthesis:
Tert-butyl 4-benzyl-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate is used as a building block in organic synthesis for constructing more complex organic molecules. Its unique structure allows for the creation of a wide range of compounds with diverse properties and applications.
Used in Medicinal and Pharmaceutical Research:
In the field of medicinal and pharmaceutical research, tert-butyl 4-benzyl-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate is used as a potential drug candidate. Its unique structure and functional groups make it a valuable starting point for the development of new therapeutic agents with specific biological activities.
Used in Chemical Industry:
Tert-butyl 4-benzyl-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate is also used in the chemical industry for various applications. Its versatility and unique structure make it suitable for the synthesis of specialty chemicals, intermediates, and other compounds with specific properties and functions.
Overall, tert-butyl 4-benzyl-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate is a valuable chemical compound with potential applications in various fields of science and industry, including organic synthesis, medicinal and pharmaceutical research, and the chemical industry. Its unique structure and functional groups contribute to its versatility and make it a promising candidate for the development of new compounds and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1352926-03-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,2,9,2 and 6 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1352926-03:
(9*1)+(8*3)+(7*5)+(6*2)+(5*9)+(4*2)+(3*6)+(2*0)+(1*3)=154
154 % 10 = 4
So 1352926-03-4 is a valid CAS Registry Number.
1352926-03-4Relevant articles and documents
HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS
-
, (2018/08/09)
The present invention provides, in part, heterocyclic spiro compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or sa
ALKYL AND ARYL DERIVATIVES OF 1-OXA-4,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN
-
, (2015/12/30)
The present invention relates to compounds of general formula (I) having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to diazaspiro undecane compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.
